Am J Perinatol 2021; 38(03): 224-230
DOI: 10.1055/s-0039-1696642
Original Article

Oxytocin Compared to Buccal Misoprostol for Induction of Labor after Term Prelabor Rupture of Membranes

Taylor S. Freret
1   Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts
,
1   Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts
,
Allison S. Bryant
1   Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts
,
Anjali J. Kaimal
1   Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts
,
Mark A. Clapp
1   Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts
› Author Affiliations

Abstract

Objective This study was aimed to determine if admission-to-delivery times vary between term nulliparous women with prelabor rupture of membranes (PROM) who initially receive oxytocin compared with buccal misoprostol for labor induction.

Study Design This is a retrospective cohort of 130 term, nulliparous women with PROM and cervical dilation of ≤2 cm who underwent induction of labor with intravenous oxytocin or buccal misoprostol. The primary outcome was time from admission to delivery. Linear regressions with log transformation were used to estimate the effect of induction agent on time to delivery.

Results Women receiving oxytocin had faster admission-to-delivery times than women receiving misoprostol (16.9 vs. 19.9 hours, p = 0.013). There were no significant differences in secondary outcomes between the groups. In the adjusted model, women who received misoprostol had a 22% longer time from admission to delivery (95% CI 5.0–42.0%) compared with women receiving oxytocin.

Conclusion In term nulliparous patients with PROM, intravenous oxytocin is associated with faster admission-to-delivery times than buccal misoprostol.

Note

This study was presented as a poster presentation at the ACOG Annual Meeting in Nashville, TN, on May 5, 2019.




Publication History

Received: 09 April 2019

Accepted: 22 July 2019

Article published online:
06 September 2019

© 2019. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Hannah ME, Ohlsson A, Farine D. et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N Engl J Med 1996; 334 (16) 1005-1010
  • 2 Committee on Practice B-O. ACOG Practice Bulletin No. 188: Prelabor rupture of membranes. Obstet Gynecol 2018; 131 (01) e1-e14
  • 3 Magos AL, Noble MC, Wong Ten Yuen A, Rodeck CH. Controlled study comparing vaginal prostaglandin E2 pessaries with intravenous oxytocin for the stimulation of labour after spontaneous rupture of the membranes. Br J Obstet Gynaecol 1983; 90 (08) 726-731
  • 4 Alfirevic Z, Aflaifel N, Weeks A. Oral misoprostol for induction of labour. Cochrane Database Syst Rev 2014; (06) CD001338
  • 5 Thorbiornson A, Vladic T, Stjernholm YV. Oral versus vaginal prostaglandin for labor induction. J Matern Fetal Neonatal Med 2017; 30 (07) 789-792
  • 6 Dobert M, Brandstetter A, Henrich W. et al. The misoprostol vaginal insert compared with oral misoprostol for labor induction in term pregnancies: a pair-matched case-control study. J Perinat Med 2018; 46 (03) 309-316
  • 7 Dorr ML, Pierson RC, Daggy J, Quinney SK, Haas DM. Buccal versus vaginal misoprostol for term induction of labor: a retrospective cohort study. Am J Perinatol 2019; 36 (07) 765-772
  • 8 Alfirevic Z, Keeney E, Dowswell T. et al. Methods to induce labour: a systematic review, network meta-analysis and cost-effectiveness analysis. BJOG 2016; 123 (09) 1462-1470
  • 9 Shetty A, Danielian P, Templeton A. Sublingual misoprostol for the induction of labor at term. Am J Obstet Gynecol 2002; 186 (01) 72-76
  • 10 Pourali L, Saghafi N, Eslami Hasan Abadi S. et al. Induction of labour in term premature rupture of membranes; oxytocin versus sublingual misoprostol; a randomised clinical trial. J Obstet Gynaecol 2018; 38 (02) 167-171
  • 11 Kim SY, Park JY, Bak SE. et al. Effect of maternal age on emergency cesarean section. J Matern Fetal Neonatal Med 2019. Doi: 10.1080/14767058.2019.1593958
  • 12 Hermann M, Le Ray C, Blondel B, Goffinet F, Zeitlin J. The risk of prelabor and intrapartum cesarean delivery among overweight and obese women: possible preventive actions. Am J Obstet Gynecol 2015; 212 (02) 241 e241-249
  • 13 Attanasio LB, Hardeman RR, Kozhimannil KB, Kjerulff KH. Prenatal attitudes toward vaginal delivery and actual delivery mode: variation by race/ethnicity and socioeconomic status. Birth 2017; 44 (04) 306-314
  • 14 Bregand-White JM, Kominiarek MA, Hibbard JU. Hypertension and patterns of induced labor at term. Pregnancy Hypertens 2017; 10: 57-63
  • 15 Committee on Practice B-O. ACOG Practice Bulletin No. 190: Gestational diabetes mellitus. Obstet Gynecol 2018; 131 (02) e49-e64
  • 16 Yin H, Hu R. A cohort study of the impact of epidural analgesia on maternal and neonatal outcomes. J Obstet Gynaecol Res 2019; 45 (08) 1435-1441
  • 17 McCoy J, Downes KL, Srinivas SK, Levine LD. Postdates induction with an unfavorable cervix and risk of cesarean. J Matern Fetal Neonatal Med 2019; 32 (17) 2874-2878
  • 18 Butt KD, Bennett KA, Crane JM, Hutchens D, Young DC. Randomized comparison of oral misoprostol and oxytocin for labor induction in term prelabor membrane rupture. Obstet Gynecol 1999; 94 (06) 994-999
  • 19 Ngai SW, Chan YM, Lam SW, Lao TT. Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes. BJOG 2000; 107 (02) 222-227
  • 20 Mozurkewich E, Horrocks J, Daley S. et al. The MisoPROM study: a multicenter randomized comparison of oral misoprostol and oxytocin for premature rupture of membranes at term. Am J Obstet Gynecol 2003; 189 (04) 1026-1030
  • 21 Lin MG, Nuthalapaty FS, Carver AR, Case AS, Ramsey PS. Misoprostol for labor induction in women with term premature rupture of membranes: a meta-analysis. Obstet Gynecol 2005; 106 (03) 593-601
  • 22 Shetty A, Mackie L, Danielian P, Rice P, Templeton A. Sublingual compared with oral misoprostol in term labour induction: a randomised controlled trial. BJOG 2002; 109 (06) 645-650
  • 23 Apgar BS. Current trends in cervical ripening and labor induction. Am Fam Physician 1999; 60 (02) 418-420
  • 24 Bricker L, Peden H, Tomlinson AJ. et al. Titrated low-dose vaginal and/or oral misoprostol to induce labour for prelabour membrane rupture: a randomised trial. BJOG 2008; 115 (12) 1503-1511
  • 25 Yount SM, Lassiter N. The pharmacology of prostaglandins for induction of labor. J Midwifery Womens Health 2013; 58 (02) 133-144 , quiz 238–139
  • 26 Arrowsmith S, Wray S. Oxytocin: its mechanism of action and receptor signalling in the myometrium. J Neuroendocrinol 2014; 26 (06) 356-369
  • 27 Kelly AJ, Tan B. Intravenous oxytocin alone for cervical ripening and induction of labour. Cochrane Database Syst Rev 2001; (03) CD003246
  • 28 Macones GA, Cahill A, Stamilio DM, Odibo AO. The efficacy of early amniotomy in nulliparous labor induction: a randomized controlled trial. Am J Obstet Gynecol 2012; 207 (05) 403 e401-405
  • 29 Seaward PG, Hannah ME, Myhr TL. et al. International Multicentre Term Prelabor Rupture of Membranes Study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. Am J Obstet Gynecol 1997; 177 (05) 1024-1029